To our knowledge, this research is the first to apply multivariate analyses to a dataset comprising 166 primary medical records to assess the influence of various factors on the clinical outcomes of NSCLC patients treated with EGFR-TKIs. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.